10/31/14 SUBK 22.96 Suffolk Bancorp $SUBK Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
10/31/14 SUBK 22.96 Suffolk Bancorp $SUBK Hit a 52 week high of 23.10 Closing the day 10/31/14 at 22.96 +0.21 +0.92% With a day low of 22.73 and a total volume of 32,100.

SUBK Recent Posts: http://investorshangout.com/Suffolk-Bancorp-SUBK-55560/

STE Steris Corp Recent Headline News

35.7% Return Seen to Date on SmarTrend STERIS Call (STE)
Comtex SmarTrend(R) - Fri Oct 31, 4:36PM CDT
SmarTrend identified an Uptrend for STERIS (NYSE:STE) on February 18th, 2014 at $45.55. In approximately 9 months, STERIS has returned 35.69% as of today's recent price of $61.80.
STE: 61.80 (+0.96)

DENTSPLY (XRAY) Beats Q3 Earnings, Misses on Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 3:30PM CDT
DENTSPLY International Inc. (XRAY) reported third-quarter 2014 adjusted earnings of 62 cents per share, which beat the Zacks Consensus Estimate by a couple of cents.
BRLI: 30.04 (+0.11), STE: 61.80 (+0.96), HSIC: 120.03 (-0.18), XRAY: 50.77 (+0.68)

STERIS Corporation to Announce Fiscal 2015 Second Quarter Financial Results on November 5, 2014
Thomson Reuters ONE - Tue Oct 28, 8:49AM CDT
Mentor, Ohio (October 28, 2014) - STERIS Corporation (NYSE: STE) today announced that it will release its fiscal 2015 second quarter financial results before the market opens on November 5, 2014, followed by a conference call at 10:00 a.m. Eastern Standard Time. The conference call can be heard live over the Internet at www.steris-ir.com or via phone by dialing 1- 800-369-8428 in the United States and Canada, or 1-773-799-3378 internationally, then referencing the password "STERIS".
STE: 61.80 (+0.96)

CONMED Q3 Earnings Rise but Revenues Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 2:10PM CDT
CONMED Corporation (CNMD) reiterated its adjusted earnings and revenue guidance for full-year 2014.
STE: 61.80 (+0.96), CNMD: 41.99 (-0.05), COO: 163.90 (+0.24)

STERIS Shares Up 31.5% Since SmarTrend's Buy Recommendation (STE)
Comtex SmarTrend(R) - Fri Oct 24, 10:57AM CDT
SmarTrend identified an Uptrend for STERIS (NYSE:STE) on February 18th, 2014 at $45.55. In approximately 8 months, STERIS has returned 31.53% as of today's recent price of $59.90.
STE: 61.80 (+0.96)

NYSE stocks posting largest percentage increases
AP - Thu Oct 23, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
CRS: 50.05 (+2.05), UFS: 41.07 (+1.28), CLV: 10.50 (+0.27), BBW: 16.95 (+0.06), CLF: 11.23 (+0.73), MTRN: 39.45 (+1.58), XRS: 31.76 (+0.04), GPI: 85.43 (+1.34), STE: 61.80 (+0.96), BRP: 23.25 (-0.05), TYL: 111.92 (+1.50), FUN: 47.26 (+0.30), UIS: 25.64 (+0.50), SIX: 40.30 (+0.08), TLLP: 56.30 (-0.34)

After Yesterday's Rally of 4.02% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Oct 22, 5:01PM CDT
STERIS (NYSE:STE) traded in a range yesterday that spanned from a low of $56.97 to a high of $59.21. Yesterday, the shares gained 4.0%, which took the trading range above the 3-day high of $56.87 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
STE: 61.80 (+0.96)

Upgrade Alert for STERIS (STE)
Comtex SmarTrend(R) - Wed Oct 22, 6:55AM CDT
STERIS (NYSE:STE) was upgraded from Market Perform to Strong Buy at Raymond James today. The stock closed yesterday at $56.68 on volume of 484,000 shares, below average daily volume of 545,000. STERIS (NYSE:STE) has potential upside of 9.1% based on a current price of $56.68 and analysts' consensus price target of $61.83. The stock should find initial support at its 50-day moving average (MA) of $55.58 and further support at its 200-day MA of $51.36.
STE: 61.80 (+0.96)

Steris (STE) to Buy UK-based Synergy Health, Save Tax - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 2:30PM CDT
Following this news, Steris' (STE) share price inched up 0.3% immediately, but eventually dropped 2.5% to close at $54.99 yesterday.
STE: 61.80 (+0.96), CAH: 78.48 (+0.29), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)

Why STERIS (STE) Stock Is Gaining in Pre-Market Trading Today
at The Street - Mon Oct 13, 8:03AM CDT
STERIS (STE) stock is rising in pre-market trading after announcing it will purchase the U.K's Synergy Health for $1.9 billion in cash and stock.
STE: 61.80 (+0.96)

Steris to spend $1.9B on UK's Synergy Health
By TOM MURPHY - AP - Mon Oct 13, 7:03AM CDT
Steris Corp. will spend about $1.9 billion to buy a British sterilization services company, as U.S. businesses continue to seek overseas incorporations despite attempts to make such tax-saving maneuvers less lucrative.
MDT: 68.16 (+0.73), STE: 61.80 (+0.96), COV: 92.44 (+0.83)

European Stocks, Asian Shares Trade Mixed in Bumpy Trading
at The Street - Mon Oct 13, 5:46AM CDT
International markets are mixed early Monday.
STE: 61.80 (+0.96), LUX: 50.80 (+0.16), STO: 22.95 (-0.21)

STERIS to Acquire Synergy Health for $1.9 Billion in Cash and Stock
Thomson Reuters ONE - Mon Oct 13, 3:02AM CDT
Combination Creates a Global Leader in Infection Prevention and Sterilization
STE: 61.80 (+0.96)

STERIS Has Returned 27.4% Since SmarTrend Recommendation (STE)
Comtex SmarTrend(R) - Fri Oct 10, 9:54AM CDT
SmarTrend identified an Uptrend for STERIS (NYSE:STE) on February 18th, 2014 at $45.54. In approximately 8 months, STERIS has returned 27.39% as of today's recent price of $58.02.
STE: 61.80 (+0.96)

Shares of STE Up 19.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Oct 03, 9:21AM CDT
SmarTrend identified an Uptrend for STERIS (NYSE:STE) on February 18th, 2014 at $45.55. In approximately 8 months, STERIS has returned 19.22% as of today's recent price of $54.30.
STE: 61.80 (+0.96)

Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade - 2014 Report for the $42 Billion Industry
M2 - Mon Sep 15, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hmf95l/surgical) has announced the addition of Supplier Relations US, LLC's new report "Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade [2014 Q3 Edition]" to their offering. The Surgical Appliance and Supplies Manufacturing Industry report contains the most recent data and analysis on the industry's key financial data, cost and pricing, competitive landscape, industry structure. Also updated are the latest trade, shipment, and inventory data available through July 2014. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. The industry's revenue for the year 2013 was reported at $42.3 billion USD, with an estimated gross profit of 44.21%. Import was valued at $12.5 billion USD from 91 countries. The industry also exported $8.8 billion USD worth of merchandise to 199 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2013 was $46.0 billion USD. In this report, you will find industry data on the following major categories: - Executive Summary - Industry Income Statement - Industry Balance Sheet - Capital Expenditure - Industry Cost Analysis - Industry Pricing Analysis - Industry Foreign Trade - Industry Structure - Competitive Landscape Companies Mentioned - Baxter International Inc. - Becton, Dickinson & Company - Boston Scientific Corporation - Cardinal Health, Inc. - Cooper Companies Inc. - Covidien - Edwards Lifesciences Corporation - Hill-Rom - Intuitive Surgical, Inc. - Invacare Corporation - Johnson & Johnson - Kimberly-Clark Corporation - Kinetic Concepts, Inc. - Medtronic, Inc. - Mine Safety Appliances Company - Pall Corporation - Royal Philips Electronics - St. Jude Medical, Inc. - STERIS Corporation - Stryker Corporation - Synthes North America - Teleflex Incorporated - West Pharmaceutical Services, Inc. - Wright Medical Group, Inc. - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/hmf95l/surgical Source: Supplier Relations US, LLC
ZMH: 111.24 (+1.96), WST: 51.25 (+1.07), BDX: 128.70 (+1.18), PHG: 27.94 (+0.46), MDT: 68.16 (+0.73), CAH: 78.48 (+0.29), KMB: 114.27 (+0.65), EW: 120.92 (+0.64), WMGIZ: 4.39 (-0.06), MSA: 57.47 (+1.91), COO: 163.90 (+0.24), BSX: 13.28 (+0.10), ISRG: 495.80 (+5.80), JNJ: 107.78 (+0.74), PLL: 91.42 (+0.50), IVC: 15.71 (+0.01), STE: 61.80 (+0.96), BAX: 70.14 (+0.08), STJ: 64.17 (-0.11), TFX: 114.12 (+1.25), SYK: 87.53 (+0.49)

23.2% Return Seen to Date on SmarTrend STERIS Call (STE)
Comtex SmarTrend(R) - Thu Sep 11, 10:07AM CDT
SmarTrend identified an Uptrend for STERIS (NYSE:STE) on February 18th, 2014 at $45.55. In approximately 7 months, STERIS has returned 23.17% as of today's recent price of $56.10.
STE: 61.80 (+0.96)

Suffolk Bancorp (SCNB) Stock Research Links

SCNB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

SEC Restructures Enforcement with Cyber Fraud Focus Ahead

Updated Category News Views 193

SEC Adjusts Enforcement Focus to Address Cyber Fraud The U.S. Securities and Exchange Commission (SEC) is making significant changes to its enforcement strategy, signaling a shift from its previous stance on cryptocurrency regulation. This restructuring involves scaling back its cryptocurrency oversight unit and creating a specialized team dedicated to tackling cyber...

Continue Reading
Short Interest Rises for DuPont: What Investors Need to Know

Updated Category News Views 316

Notable Shifts in DuPont Stock Sentiment The whispers in the market are getting harder to ignore—DuPont de Nemours Inc (NYSE:DD) is seeing some serious strife under its surface. Just recently, the short interest on this stock has crept up by a hefty 23.76%. Folks, that’s not just a passing trend; it’s a flashing neon sign that says something's off in the minds of...

Continue Reading
Achieve Fast Muscle Growth With CrazyBulk Supplements

Updated Category News Views 206

Unlocking Your Potential: The Power of Muscle Building In an age where fitness lies at the forefront of many people's aspirations, finding a solid workout routine tailored for muscle growth has never been more critical. For men looking for rapid muscle development, CrazyBulk muscle gaining supplements are setting a new standard in the fitness community. This approach...

Continue Reading
Goldswarm Honey Unites Beekeeping Through Innovative Support

Updated Category News Views 146

Goldswarm Honey Takes a Sweet Step for Pollinators A new partnership has blossomed between Goldswarm Honey and a renowned research institution aimed at safeguarding the vital pollinators that are essential to a significant portion of our food supply. This collaboration not only highlights a deep commitment to environmental conservation but also bridges two cultures...

Continue Reading
Idexx Laboratories Navigates Revenue Growth Challenges Ahead

Updated Category News Views 97

Idexx Laboratories Faces Revenue Growth Challenges Idexx Laboratories Inc (NASDAQ: IDXX) reported its third-quarter earnings, showcasing an adjusted EPS of $2.79. This reflected a remarkable 12% increase compared to the previous year, surpassing analyst expectations which were set at $2.68. Sales Performance Overview During this quarter, the company achieved sales...

Continue Reading